ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer

por Wang, H. H., Plukker, J. Th. M., Hospers, G. A. P.
Publicado 2020

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

por Hospers, G A P, Eisenhauer, E A, Vries, E G E de
Publicado 1999

Survival of non-Western first generations immigrants with stomach cancer in North East Netherlands

por Siemerink, E J M, van der Aa, M A, Siesling, S, Hospers, G A P, Mulder, N H
Publicado 2011

Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes

por Calogero, A, Timmer-Bosscha, H, Koops, H Schraffordt, Tiebosch, A T M G, Mulder, N H, Hospers, G A P
Publicado 2000

Checks and Balances in Autoimmune Vasculitis

por Hid Cadena, Rebeca, Abdulahad, Wayel H., Hospers, G. A. P., Wind, T. T., Boots, Annemieke M. H., Heeringa, Peter, Brouwer, Elisabeth
Publicado 2018

Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a c...

por Mintjens-Jager, E M W, Vos, M E, Kats-Ugurlu, G, Hospers, G A P, Rutgers, A, van Meurs, M
Publicado 2020

Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion

por Admiraal, J. M., Hoekstra-Weebers, J. E. H. M., Schröder, C. P., Tuinier, W., Hospers, G. A. P., Reyners, Anna K. L.
Publicado 2019

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy...

por Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.
Publicado 2023

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

por Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.
Publicado 2023

Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport

por Buursma, A R, van Dillen, I J, van Waarde, A, Vaalburg, W, Hospers, G A P, Mulder, N H, de Vries, E F J
Publicado 2004

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

por de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Publicado 2017

Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not

por Zwart, W.H., Dijkstra, E.A., Putter, H., Marijnen, C.A.M., Nilsson, P.J., van de Velde, C.J.H., van Etten, B., Hospers, G.A.P., Glimelius, B.
Publicado 2023

Enhanced pulmonary uptake on (18)F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

por Venema, C. M., de Vries, E. F. J., van der Veen, S. J., Dorrius, M. D., van Kruchten, M., Schröder, C. P., Hospers, G. A. P., Glaudemans, A. W. J. M.
Publicado 2019

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results o...

por Bisschop, C., van Dijk, T. H., Beukema, J. C., Jansen, R. L. H., Gelderblom, H., de Jong, K. P., Rutten, H. J. T., van de Velde, C. J. H., Wiggers, T., Havenga, K., Hospers, G. A. P.
Publicado 2017

Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET

por Antunes, I. F., Hospers, G. A. P., Sijbesma, J. W. A., Boerema, A. S., van Waarde, A., Glaudemans, A. W. J. M, Dierckx, R. A. J. O., de Vries, E. G. E., de Vries, E. F. J.
Publicado 2020

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

por Koleva-Kolarova, R G, Greuter, M J W, van Kruchten, M, Vermeulen, K M, Feenstra, T, Buskens, E, Glaudemans, A W J M, de Vries, E F J, de Vries, E G E, Hospers, G A P, de Bock, G H
Publicado 2015

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial

por Dijkstra, E.A., Zwart, W.H., Nilsson, P.J., Putter, H., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Frödin, J.E., Nygren, P., Østergaard, L., Kersten, C., Verbiené, I., Cervantes, A., Hendriks, M.P., Capdevila, J., Edhemovic, I., van de Velde, C.J.H., Marijnen, C.A.M., van Etten, B., Hospers, G.A.P., Glimelius, B.
Publicado 2023

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

por Franken, M.G., Leeneman, B., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., van den Eertwegh, A.J.M., de Groot, J.W.B., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R.S., Suijkerbuijk, K.P.M., van der Veldt, A.A.M., Westgeest, H.M., Wouters, M.W.J.M., Haanen, J.B.A.G., Uyl-de Groot, C.A.
Publicado 2021

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial

por Mulder, E. E. A. P., de Joode, K., Litière, S., ten Tije, A. J., Suijkerbuijk, K. P. M., Boers-Sonderen, M. J., Hospers, G. A. P., de Groot, J. W. B., van den Eertwegh, A. J. M., Aarts, M. J. B., Piersma, D., van Rijn, R. S., Kapiteijn, E., Vreugdenhil, G., van den Berkmortel, F. W. P. J., Hoop, E. Oomen-de, Franken, M. G., Ryll, B., Rutkowski, P., Sleijfer, S., Haanen, J. B. A. G., van der Veldt, A. A. M.
Publicado 2021